France· FR:62676633
ALFATIL 125 mg/5 ml, poudre pour suspension buvable
A cefaclor product containing céfaclor, registered in France by LABORATOIRES ETHYPHARM, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Cefaclor is registered in 11 of 19 countries.
Countries holding a registration under ATC J01DC04 (cefaclor), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 6 of them publish a price we can compare per daily dose
Cefaclor · ATC J01DC04
11 / 19 countries
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefaclor costs, country by country.
Normalised to the WHO defined daily dose (1 g), the median price runs from $1.23 in Spain to $2.73 in France — a ×2.2 gap.
- France: $2.73 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Cefaclor · price per daily dose (1 g)
USD · FX 28 Sept 2026
- FR France$2.73
- IT Italy$2.32
- ES Spain$1.23
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CÉFACLOR
- Manufacturer
- LABORATOIRES ETHYPHARM
- Country
- France (FR)
- ATC code
- J01DC04
- ATC class
- Cefaclor
- Defined daily dose
- 1 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009323324271 flacon(s) polyéthylène haute densité (PEHD) de 39,12 g avec cuillère-mesure avec mesurette(s) graduée(s) polyéthylène polystyrèneEUR 2.89
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
102 interactions on record for cefaclor.
Graded by severity as the source publishes them — 18 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefaclor · interactions on record
102 records
- 18 moderate
- 84 info
Most severe, free to view
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Sodium picosulfateA06AB08moderate
- Magnesium oxideA06AD02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefaclor in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBacticlor MR 375mg tabletsSun Pharma UK Ltd
- ItalyBACTIGRAMAESCULAPIUS FARMACEUTICI S.R.L.
- GermanyCefaclor1 A Pharma Gmbh
- Japanセファクロル長生堂製薬
- FinlandCefaklor RanbaxyRanbaxy UK Limited
- PolandCeclorTeva Pharmaceuticals Polska Sp. z o.o.
- United StatesCefaclorTeva Pharmaceuticals USA, Inc.
- IrelandDistaclor 125 mg/5 ml Granules for Oral SuspensionFlynn Pharma Limited
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Ceclor, Ceclor Forte
- Bulgaria · Медоклор, Цефаклор Алкалоид
- Cyprus · C E C L O R Mr, Ceclor
- Germany · Cefaclor, Cefaclor Al
- United Kingdom (Northern Ireland) · Cefaclor, Cefaclor Clydesdale Pharma
- Greece · Ceclor, Ceclor Mr
- Hungary · Ceclor, Ceclor Forte
- Ireland · Distaclor, Distaclor La
- Italy · Bactigram, Cefaclor Eg
- Malta · Ceclor
- Netherlands · Cefaclor Sandoz
- Poland · Ceclor, Ceclor Mr
- Portugal · Ceclor, Ceclor Retard
- Romania · Ceclor, Cefaclor Arena
- Slovenia · Ceclor
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a08b3f57-995b-459b-b706-99840af61ff5 GET /v1/drugs/a08b3f57-995b-459b-b706-99840af61ff5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62676633",
"date_amm": "1981-06-10",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CÉFACLOR",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour suspension buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about cefaclor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.